Status:
COMPLETED
Effects on Health Status in Patients Early Discharged After Primary Percutaneous Coronary Intervention (PCI)
Lead Sponsor:
Helse Stavanger HF
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
Phase:
NA
Brief Summary
In patients with ST elevation myocardial infarction (STEMI)treated with primary percutaneous coronary intervention (PPCI) a subset with low risk for late complications can be identified. Early dischar...
Detailed Description
The safety and feasibility of early discharge of low-risk STEMI treated with thrombolysis or PPCI patients have previously been investigated. It is possible to identify a subset of patients with very ...
Eligibility Criteria
Inclusion
- ST elevation acute myocardial infarction
- Undergoing primary PCI
Exclusion
- Zwolle low risk criteria score \>4
- Re-infarction, post AMI ischemia.
- Need for urgent repeat invasive procedures.
- Non-cardiac complication (bleeding, stroke oa.) or concomitant diseases likely to increase length of hospital stay.
- Patient or caring physician refuse to early discharge or study inclusion.
- Early discharge impossible due to social, nursing or family reasons.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01244841
Start Date
September 1 2010
End Date
November 1 2012
Last Update
May 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stavanger University Hospital
Stavanger, Rogaland, Norway, 4068